Premium
Comparison of Primary Orchiectomy and Polyoestradiol Phosphate in the Treatment of Advanced Prostatic Cancer
Author(s) -
HAAPIAINEN R.,
RANNIKKO S.,
ALFTHAN O.
Publication year - 1990
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1990.tb14872.x
Subject(s) - orchiectomy , medicine , cancer , urology , prostate cancer , oncology , disease
Summary— The primary clinical efficacy of orchiectomy and polyoestradiol phosphate (PEP) 160 mg/month i.m. was evaluated by progression and cancer mortality rates in a Finnish multicentre study comprising 200 prostatic cancer patients. After the minimum follow‐up time of 2 years there was a significant difference between the groups–orchiectomy delayed progression of the disease more effectively. The follow‐up time is rather short for prostatic cancer, but on the basis of this preliminary study the dose of PEP seems to be insufficient in the treatment of advanced prostatic cancer.